To the best of our knowledge, only one study previously tested a similar approach, in which valproic acid, a histone deacetylase inhibitor, further improved a CD8+ T cell response against murine melanoma tumor-associated antigens (TAAs) initially primed by an HSV-expressing granulocyte macrophage-colony-stimulating factor.41 The gene discussed is CD8A; the disease is neoplasm.